INNVIERTE
Innvierte allocates more than 350 million euros in October and November to eight new co-investments in venture capital and five investment vehicles.
Estas operaciones, realizadas en EBTs o innovadoras, están destinadas a diversos desarrollos de los sectores Generalista, Bio, Salud y Agroalimentación, TIC, Industria, Energía y Medioambiente
Ver sección
The CDTI commits more than 1,000 million euros in venture capital funds and co-investments through Innvierte.
En el segundo semestre del año, Innvierte adquiere compromisos en 17 fondos de capital riesgo y ha aprobado 28 nuevas coinversiones, dos de ellas estratégicas
Ver sección
CDTI Innovation invests, together with GPC, in TEBRIO, a biotechnology company in the insect protein sector. 
La aportación comprometida por el CDTI Innovación es de 6.931.000 euros
Ver sección
CDTI Innovation invests, together with INVEREADY FIRST CAPITAL III PARALLEL, F.C.R. and INVEREADY FIRST CAPITAL III S.C.R.E., S.A., in UNION AVATARS, a company developing an avatar creation platform.
The input committed by the CDTI innovation is eur 328
Ver sección
The CDTI Innovation invests, together with ELEWIT, S.A. and EIT InnoEnergy, GLOBAL ZELEROS, S.L., company that develops hyperloop technologies and offers solutions of electrification and automation in the area of mobility
The input committed by the CDTI innovation is €540,000
Ver sección
Innvierte spent in september around 41 million euros to two new coinversiones in risk capital and an investment vehicle
En 2024 el CDTI, a través de Innvierte, ha cerrado coinversiones en 44 empresas con compromiso 67,2M€ e inversiones en 5 veh. de inversión con compromiso 295M€
Ver sección
The CDTI Innovation invests together with Group Construcía, Meroil, Nolabey Grup and Evolvia a leading representative in revaluation of cellulose, Honext Materials, S.L.
Ver sección
Innvierte spent in july and august around 300 million to eur 15 new coinversiones in risk capital and investment vehicles 4
These operations, undertaken in EBTs or innovative companies, are aimed at various developments of the bio, health, ICT, energy and environment
Ver sección
The CDTI Innovation invests, together with PARTNERS, in ASABYS ALLOX, company that develops a technology for the identification of sites in key proteins alostéricos
The input committed by the CDTI innovation is €1,800,000
Ver sección
Subscribe to INNVIERTE